
1. bioorg med chem lett. 2015 feb 1;25(3):459-61. doi: 10.1016/j.bmcl.2014.12.051.
epub 2014 dec 19.

hydroxamic acid based histone deacetylase inhibitors confirmed activity
against malaria parasite.

giannini g(1), battistuzzi g(2), vignola d(2).

author information: 
(1)r&d sigma-tau industrie farmaceutiche riunite s.p.a., via pontina km 30,400,
i-00040 pomezia, roma, italy. electronic address: giuseppe.giannini@sigma-tau.it.
(2)r&d sigma-tau industrie farmaceutiche riunite s.p.a., via pontina km 30,400,
i-00040 pomezia, roma, italy.

recent studies highlighted key role regulating gene transcription, in
both eukaryotes prokaryotes, enzymes control acetylation and
deacetylation histones. particular, inhibitors histone deacetylases
(hdac-is) shown effective controlling development many
parasites, plasmodium malaria. report results a
study aimed evaluating antiparasitic effect two classes hdac-is bearing 
different zinc binding group (hydroxamic acid vs thiol). study showed that
only hydroxamic acid based hdac inhibitors active, plasmodium
falciparum sensitive parasite, low double-digit to
single-digit nanomolar range vitro activities. among three derivatives
evaluated also vivo, st8086aa1 (8) effectively inhibited 88% the
development plasmodium falciparum.

copyright Â© 2014 elsevier ltd. rights reserved.

doi: 10.1016/j.bmcl.2014.12.051 
pmid: 25563890  [indexed medline]

